Advertisement

Approach to Patients with Skin Manifestations

  • Richard D. SontheimerEmail author
Chapter

Abstract

A hypothetical case of subacute cutaneous lupus erythematosus (SCLE) will be presented and discussed to illustrate the author’s approach to diagnosis and management of complex medical dermatology problems involving rheumatologic diseases. The case discussion will involve three different time points in the patient’s disease course to illustrate key elements of the initial evaluation and diagnosis of such patients, the recognition and management of adverse effects of treatment, and the management of disease complications resulting from the development of overlapping autoimmune disorders during a patient’s disease course.

Keywords

Allergic Contact Dermatitis Skin Change Alopecia Areata Subacute Cutaneous Lupus Erythematosus Polymorphous Light Eruption 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The author’s understanding of the diagnosis and management of rheumatologic skin disorders was built up on a foundation of knowledge and experience that was shared with him by several more senior American academic dermatologists. Those individuals include James N. Gilliam (deceased), Thomas T. Provost (deceased), Denny L. Tuffanelli (deceased), Sam L. Moschella, and Irwin M. Braverman. Several of these individuals served as mentors to the author providing him with instrumental career development guidance. The author will be eternally grateful for the support these individuals provided to him and the contributions they as a group made to our modern understanding of rheumatologic skin disease.

References

  1. 1.
    Greenwald RA. Greenwald’s law of lupus. J Rheumatol. 1992;19:1490.PubMedGoogle Scholar
  2. 2.
    Candore G, Modica MA, Lio D, et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother. 2003;57:274–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Jewell ML, McCauliffe DP. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol. 2000;42:983–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Iglesias ME, Espana A, Idoate MA, Quintanilla E. Generalized skin reaction following tinea pedis (dermatophytids). J Dermatol. 1994;21:31–4.PubMedGoogle Scholar
  5. 5.
    Lowe G, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011;164:465–72.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations